Canada · Health Canada Drug Product Database
WATKINS J.R.
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 53286
- DIN
- 02233352
- Form
- Tablet
- Company as listed by source
- WATKINS INCORPORATED
- Source status
- Cancelled Post Market (2008-09-10)
- Source last updated
- 2025-03-22
Source-listed ingredients
- BETA-CAROTENE (PROVITAMIN A) — 7500 UNIT
- ASCORBIC ACID — 50 MG
- VITAMIN D (VITAMIN D3) — 200 UNIT
- VITAMIN E (D-ALPHA TOCOPHERYL ACID SUCCINATE, DL-ALPHA TOCOPHERYL ACETATE) — 15 UNIT
- VITAMIN B1 (THIAMINE MONONITRATE) — 0.75 MG
- VITAMIN B2 — 0.85 MG
- NICOTINAMIDE — 10 MG
- VITAMIN B6 (PYRIDOXINE HYDROCHLORIDE) — 1 MG
- FOLIC ACID — 0.2 MG
- VITAMIN B12 (VITAMIN B12) — 3 MCG
- BIOTIN — 150 MCG
- D-PANTOTHENIC ACID (CALCIUM D-PANTOTHENATE) — 5 MG
- IRON (FERROUS FUMARATE) — 2.25 MG
- IODINE (POTASSIUM IODIDE) — 0.075 MG
- ZINC (ZINC HVP CHELATE, ZINC CITRATE) — 7.5 MG
- COPPER (CUPRIC SULFATE) — 1 MG
- MANGANESE (MANGANESE SULFATE) — 1 MG
- MOLYBDENUM (SODIUM MOLYBDATE) — 25 MCG
- SILICON (SILICON DIOXIDE) — 8.5 MG
- SELENIUM (SELENIUM HVP CHELATE) — 35 MCG
- CHROMIUM (CHROMIC CHLORIDE) — 60 MCG
These values do not establish equivalence or a dose recommendation.
Packages
- 60
Source and coverage
Open Health Canada Drug Product Database →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse Canada records →